0001933414-23-000061.txt : 20230811
0001933414-23-000061.hdr.sgml : 20230811
20230811191115
ACCESSION NUMBER: 0001933414-23-000061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Congleton Jon
CENTRAL INDEX KEY: 0001644975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41614
FILM NUMBER: 231165710
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mineralys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001933414
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 N. RADNOR CHESTER ROAD
STREET 2: SUITE F200
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: (888) 378-6240
MAIL ADDRESS:
STREET 1: 150 N. RADNOR CHESTER ROAD
STREET 2: SUITE F200
CITY: RADNOR
STATE: PA
ZIP: 19087
4
1
wf-form4_169179546088184.xml
FORM 4
X0508
4
2023-08-11
0
0001933414
Mineralys Therapeutics, Inc.
MLYS
0001644975
Congleton Jon
150 N. RADNOR CHESTER ROAD,
SUITE F200
RADNOR
PA
19087
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-08-11
4
P
0
2000
12.89
A
1040318
D
The price reported is the weighted-average purchase price, purchased in multiple transactions at prices ranging from $12.8522 to $12.9257. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
/s/ Adam Levy, Attorney-in-fact
2023-08-11